Plus Therapeutics Inc. (NASDAQ:PSTV) has a beta value of 0.42 and has seen 1,759,406 shares traded in the last trading session. The company, currently valued at $54.88 Million, closed the last trade at $2.6 per share which meant it gained $0.32 on the day or 14.04% during that session. The PSTV stock price is -108.46% off its 52-week high price of $5.42 and 46.15% above the 52-week low of $1.4. If we look at the company’s 10-day average daily trading volume, we find that it stood at 275.95 Million shares traded. The 3-month trading volume is 1.11 Million shares.
The consensus among analysts is that Plus Therapeutics Inc. (PSTV) is a Buy stock at the moment, with a recommendation rating of 1.7. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 4 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.33.
Plus Therapeutics Inc. (NASDAQ:PSTV) trade information
Sporting 14.04% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, May 03 when the PSTV stock price touched $2.72-4 or saw a rise of 4.41%. Year-to-date, Plus Therapeutics Inc. shares have moved 28.71%, while the 5-day performance has seen it change 11.11%. Over the past 30 days, the shares of Plus Therapeutics Inc. (NASDAQ:PSTV) have changed 5.69%. Short interest in the company has seen 496.72 Million shares shorted with days to cover at 447.5.
Wall Street analysts have a consensus price target for the stock at $6.81, which means that the shares’ value could jump 161.92% from current levels. The projected low price target is $6 while the price target rests at a high of $8. In that case, then, we find that the current price level is +207.69% off the targeted high while a plunge would see the stock lose 130.77% from current levels.
Plus Therapeutics Inc. (PSTV) estimates and forecasts
Earnings growth for 2021 is a modest +32.9%.
Plus Therapeutics Inc. (NASDAQ:PSTV)’s Major holders
Insiders own 1.32% of the company shares, while shares held by institutions stand at 2.32% with a share float percentage of 2.35%. Investors are also buoyed by the number of investors in a company, with Plus Therapeutics Inc. having a total of 26 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 121.04 Thousand shares worth more than $244.5 Thousand. As of December 30, 2020, Blackrock Inc. held 0.57% of shares outstanding.
The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 106.1 Thousand shares as of December 30, 2020. The firm’s total holdings are worth over $214.32 Thousand and represent 0.5% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of December 30, 2020, the former fund manager holds about 0.1% shares in the company for having 21236 shares of worth $42.9 Thousand while later fund manager owns 6.34 Thousand shares of worth $18.06 Thousand as of February 27, 2021, which makes it owner of about 0.03% of company’s outstanding stock.